The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Overview of PDEs and Their Regulation
Omori, K., & Kotera, J. (2007) · Circulation Research · doi:10.1161/01.res.0000256354.95791.f1 · Cited by 796
HOUSLAY, M. D., & ADAMS, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 763
Toward a molecular definition of long-term memory storage
Bailey, C. H., Bartsch, D., & Kandel, E. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13445 · Cited by 691
DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., et al. (2005) · Science · doi:10.1126/science.1112915 · Cited by 648 · cited 1×
“7 ) also explains recent peptide-array, yeast-two-hybrid and immunoprecipitation studies demonstrating that partner proteins can decrease PDE4 activit”
BackgroundKeynote review: Phosphodiesterase-4 as a therapeutic target
Houslay, M. D., Schafer, P., & Zhang, K. Y. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03622-6 · Cited by 635
Lehnart, S. E., Wehrens, X. H. T., Reiken, S., Warrier, S., Belevych, A. E., Harvey, R. D., Richter, W., Jin, S.-L. C., Conti, M., & Marks, A. R. (2005) · Cell · doi:10.1016/j.cell.2005.07.030 · Cited by 517
RAR and RXR modulation in cancer and metabolic disease
Altucci, L., Leibowitz, M. D., Ogilvie, K. M., de Lera, A. R., & Gronemeyer, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2397 · Cited by 517
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
Card, G. L., England, B. P., Suzuki, Y., Fong, D., Powell, B., Lee, B., Luu, C., Tabrizizad, M., Gillette, S., Ibrahim, P. N., et al. (2004) · Structure · doi:10.1016/j.str.2004.10.004 · Cited by 432
Sette, C., & Conti, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16526 · Cited by 409
PDE4 inhibitors: current status
Spina, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.307 · Cited by 340
Bolger, G., Michaeli, T., Martins, T., St John, T., Steiner, B., Rodgers, L., Riggs, M., Wigler, M., & Ferguson, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6558 · Cited by 315
Robichaud, A., Stamatiou, P. B., Jin, S.-L. C., Lachance, N., MacDonald, D., Laliberté, F., Liu, S., Huang, Z., Conti, M., & Chan, C.-C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15506 · Cited by 267
MacKenzie, S. J., Baillie, G. S., McPhee, I., MacKenzie, C., Seamons, R., McSorley, T., Millen, J., Beard, M. B., van Heeke, G., & Houslay, M. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704743 · Cited by 260
Robichaud, A., Stamatiou, P. B., Jin, S.-L. C., Lachance, N., MacDonald, D., Laliberté, F., Liu, S., Huang, Z., Conti, M., & Chan, C.-C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215506 · Cited by 259
MacKenzie, S. J., Baillie, G. S., McPhee, I., Bolger, G. B., & Houslay, M. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.22.16609 · Cited by 238
Verde, I., Pahlke, G., Salanova, M., Zhang, G., Wang, S., Coletti, D., Onuffer, J., Jin, S.-L. C., & Conti, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006546200 · Cited by 217
Millar, J. K., Christie, S., Anderson, S., Lawson, D., Loh, D. H.-W., Devon, R. S., Arveiler, B., Muir, W. J., Blackwood, D. H. R., & Porteous, D. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000784 · Cited by 202
Improving Memory: A Role for Phosphodiesterases
Blokland, A., Schreiber, R., & Prickaerts, J. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698855 · Cited by 174
Bolger, G. B., Peden, A. H., Steele, M. R., MacKenzie, C., McEwan, D. G., Wallace, D. A., Huston, E., Baillie, G. S., & Houslay, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303269200 · Cited by 168
Murdoch, H., Mackie, S., Collins, D. M., Hill, E. V., Bolger, G. B., Klußmann, E., Porteous, D. J., Millar, J. K., & Houslay, M. D. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1493-07.2007 · Cited by 167
HOFFMANN, R., WILKINSON, I. R., McCALLUM, J. F., ENGELS, P., & HOUSLAY, M. D. (1998) · Biochemical Journal · doi:10.1042/bj3330139 · Cited by 165
Suncus murinus: A new experimental model in emesis research
Ueno, S., Matsuki, N., & Saitō, H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90229-3 · Cited by 161
Bolger, G. B., Baillie, G. S., Li, X., Lynch, M. J., Herzyk, P., Mohamed, A. Y., Smoot, L. H. M., McCahill, A., Hundsrucker, C., Klußmann, E., et al. (2006) · Biochemical Journal · doi:10.1042/bj20060423 · Cited by 161
Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs
Zhang, H. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168092 · Cited by 152
Beard, M., Olsen, A. E., Jones, R. E., Erdoğan, S., Houslay, M. D., & Bolger, G. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10349 · Cited by 132
PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway
Robichaud, A., Savoie, C., Stamatiou, P. B., Tattersall, F. D., & Chan, C. C. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00142-8 · Cited by 131
Shakur, Y., Pryde, J. G., & Houslay, M. D. (1993) · Biochemical Journal · doi:10.1042/bj2920677 · Cited by 131
Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease
DeMarch, Z., Giampà, C., Patassini, S., Bernardi, G., & Fusco, F. R. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.010 · Cited by 121
Assessing the emetic potential of PDE4 inhibitors in rats
Robichaud, A., Savoie, C., Stamatiou, P. B., Lachance, N., Jolicoeur, P., Rasori, R., & Chan, C. C. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704457 · Cited by 120
McCahill, A., McSorley, T., Huston, E., HILL, E., Lynch, M. J., Gall, I., Keryer, G., Lygren, B., Taskén, K., & Vanheeke, G. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.003 · Cited by 115
Discovery of selective PDE4B inhibitors
Naganuma, K., Omura, A., Maekawara, N., Saitoh, M., Ohkawa, N., Kubota, T., Nagumo, H., Kodama, T., Takemura, M., Ohtsuka, Y., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.121 · Cited by 111
Bolger, G. B., McCahill, A., Huston, E., Cheung, Y.-F., McSorley, T., Baillie, G. S., & Houslay, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303772200 · Cited by 107
Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret
Robichaud, A., Tattersall, F. D., Choudhury, H., & Rodger, I. W. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00190-7 · Cited by 99
Activation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation
Lim, J., Pahlke, G., & Conti, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19677 · Cited by 94
Mihara, T., Mihara, K., Yarimizu, J., Mitani, Y., Matsuda, R., Yamamoto, H., Aoki, S., Akahane, A., Iwashita, A., & Matsuoka, N. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121962 · Cited by 76
Development status of second generation PDE4 inhibitors for asthma and COPD: the story so far.
Giembycz, M. A. (2002) · PubMed · Cited by 74
Brideau, C., van Staden, C., Styhler, A., Rodger, I. W., & Chan, C. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702387 · Cited by 68
Gene Composer: database software for protein construct design, codon engineering, and gene synthesis
Lorimer, D. D., Raymond, A. C., Walchli, J., Mixon, M. B., Barrow, A., Wallace, E., Grice, R., Burgin, A. B., & Stewart, L. J. (2009) · BMC Biotechnology · doi:10.1186/1472-6750-9-36 · Cited by 62
Self-citationThe Molecular Basis for Different Recognition of Substrates by Phosphodiesterase Families 4 and 10
Wang, H., Robinson, H. H., & Ke, H. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.060 · Cited by 61
Raymond, A. C., Lovell, S., Lorimer, D. D., Walchli, J., Mixon, M. B., Wallace, E., Thompkins, K. B., Archer, K., Burgin, A. B., & Stewart, L. J. (2009) · BMC Biotechnology · doi:10.1186/1472-6750-9-37 · Cited by 55
Self-citationHirose, R., Manabe, H., Nonaka, H., Yanagawa, K., Akuta, K., Sato, S., Ohshima, E., & Ichimura, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.045 · Cited by 34
Zhang, J., Snyder, R. D., Herman, E. H., Knapton, A. D., Honchel, R., Miller, T. J., Espandiari, P., Goodsaid, F. M., Rosenblum, I. Y., Hanig, J. P., et al. (2008) · Toxicologic Pathology · doi:10.1177/0192623308322308 · Cited by 30
A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function
Chambers, R. J., Abrams, K., Castleberry, T. A., Cheng, J. B., Fisher, D. A., Kamath, A. V., Marfat, A., Nettleton, D. O., Pillar, J. D., Salter, E. D., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.026 · Cited by 7
Cited by
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Self-citationMillan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Advances in targeting cyclic nucleotide phosphodiesterases
Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 776
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Li, H., Zuo, J., & Tang, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01048 · Cited by 580
Metadata
- Authors
- Burgin, A. B., Magnusson, O. T., Singh, J., Witte, P., Staker, B. L., Bjornsson, J. M., Thorsteinsdottir, M., Hrafnsdottir, S., Hagen, T., Kiselyov, A. S., Stewart, L. J., & Gurney, M. E.
- Venue
- Nature Biotechnology
- Published
- 2010-01
- Volume
- 28
- Issue
- 1
- Pages
- 63-70
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W1997277329
- Cited by
- 397
- References
- 44
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.